Responsiveness of developing dental tissues to fibroblast growth factors: Expression of splicing alternatives of FGFR1, -2, -3, and of FGFR4; and stimulation of cell proliferation by FGF-2, -4, -8, and -9

被引:0
|
作者
Kettunen, P [1 ]
Karavanova, I [1 ]
Thesleff, I [1 ]
机构
[1] Univ Helsinki, Dev Biol Programme, Inst Biotechnol, Viikki Bioctr, FIN-00014 Helsinki, Finland
来源
DEVELOPMENTAL GENETICS | 1998年 / 22卷 / 04期
关键词
tooth development; FGFR; FGF; epithelial-mesenchymal interactions; cell differentiation; induction; enamel knot; cell proliferation;
D O I
10.1002/(SICI)1520-6408(1998)22:4<374::AID-DVG7>3.0.CO;2-3
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
To elucidate the roles of fibroblast growth factors (FGF) in tooth development, we have analyzed the expression patterns of fibroblast growth factor receptors (FGFR) in mouse teeth by in situ hybridization and studied the effects of FGF-2, -4, -8, and -9 on cell proliferation in vitro by local application with beads on isolated dental mesenchymes. mRNAs of FGFR-1, -2, and -3 were localized by probes specific for the alternative splice variants IIIb and IIIc. The expression patterns of FGFR1, -2, and -3 were completely different, and the two splicing variants of FGFR1 and 2 exhibited different expression domains. FGFR4 was not expressed in the developing teeth. The IIIb splice forms of FGFR1 and -2 were expressed in the dental epithelium during morphogenesis. The IIIc splice form of FGFR1 was expressed both in epithelium and mesenchyme whereas FGFR2 IIIc was confined to the mesenchymal cells of the denial Follicle. Both splice forms of FGFR3 were expressed in denial papilla mesenchyme. None of the FGF-receptors was detected in the primary enamel knot, the putative signaling center regulating tooth morphogenesis. This may explain the fact that enamel knot cells do not proliferate, although they express intensely mitogenic FGFs. Beads releasing FGF-2, -4, -8, or -9 proteins stimulated cell proliferation in cultured denial mesenchymes. These data, together with our earlier data on FGF expression [Kettunen and Thesleff (1998): Dev Dyn 211:256-268] suggest that FGF-8 and -9 mediate epitheliol-mesenchymal interactions during tooth initiation. During advancing morphogenesis FGF-3, -4, and -9 may act both on mesenchyme and epithelium. Finally, the intense expression of FGFR1 in odontoblasts and ameloblasts, and FGFR2 IIIb in ameloblasts suggests that FGFs participate in regulation of their differentiation and/or secretory functions. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:374 / 385
页数:12
相关论文
共 41 条
  • [21] Growth factors FGF8 and FGF2 and their receptor FGFR1, transcriptional factors Msx-1 and MSX-2, and apoptotic factors p19 and RIP5 participate in the early human limb development
    Becica, Tina
    Kero, Darko
    Vukojevic, Katarina
    Mardesic, Snjezana
    Saraga-Babic, Mirna
    ACTA HISTOCHEMICA, 2018, 120 (03) : 205 - 214
  • [22] Neutrophil MMP-9 Proenzyme, Unencumbered by TIMP-1, Undergoes Efficient Activation in Vivo and Catalytically Induces Angiogenesis via a Basic Fibroblast Growth Factor (FGF-2)/FGFR-2 Pathway
    Ardi, Veronica C.
    Van den Steen, Philippe E.
    Opdenakker, Ghislain
    Schweighofer, Bernhard
    Deryugina, Elena I.
    Quigley, James P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (38) : 25854 - 25866
  • [23] BI089-100, A NOVEL GLYCOPEGYLATED FIBROBLAST GROWTH FACTOR 21(FGF21), ACTIVATES FGF RECEPTORS (FGFR) 1c, 2c AND 3c BUT NOT FGFR4 IN L6 CELLS TRANSFECTED WITH THE FOUR DIFFERENT HUMAN FGFRS AND BETA-KLOTHO (KLB)
    Moti, Rosenstock
    Di Marco, Annalise
    Auciello, Giulio
    Bresciani, Alberto
    Mansbach, Hank
    Margalit, Maya
    HEPATOLOGY, 2020, 72 : 318A - 318A
  • [24] FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1
    Guo, Chaoqin
    Zhou, Nana
    Lu, Yisong
    Mu, Mingshan
    Li, Zilin
    Zhang, Xu
    Tu, Linglan
    Du, Jingyang
    Li, Xiangyu
    Huang, Dongsheng
    Xu, Qiuran
    Zheng, Xiaoliang
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 170
  • [25] Raised circulating fibroblast growth factor 21 (FGF21) coupled with reduced adipose tissue BetaKlotho and FGF21 receptor 1 (FGFR1) expression in Type 2 diabetes may in part explain FGF21 resistance
    Piya, M. K.
    Harte, A. L.
    Kyrou, I.
    Chitari, M. V.
    Tripathi, G.
    Kumar, S.
    McTernan, P. G.
    DIABETIC MEDICINE, 2013, 30 : 3 - 3
  • [26] Changes in proliferation, differentiation, fibroblast growth factor 2 responsiveness and expression of syndecan-4 and glypican-1 with turkey satellite cell age
    Harthan, Laura B.
    McFarland, Douglas C.
    Velleman, Sandra G.
    DEVELOPMENT GROWTH & DIFFERENTIATION, 2013, 55 (05) : 622 - 634
  • [27] Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in Nonfunctioning Pituitary Adenomas: A High Throughput TMA, Immunohistochemical Study
    Ramirez, Claudia
    Cheng, Sonia
    Vargas, Guadalupe
    Asa, Sylvia L.
    Ezzat, Shereen
    Gonzalez, Baldomero
    Cabrera, Lourdes
    Guinto, Gerardo
    Mercado, Moises
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05): : 1745 - 1751
  • [28] Discovery of novel pyrido[2,3-b]pyrazine as fibroblast growth factor receptor (FGFR-1, 2, 3 & 4) kinase inhibitors with nanomolar affinity
    Angibaud, P.
    Querolle, O.
    Berdini, V.
    Saxty, G.
    Cleasby, A.
    Colombel, H.
    Csoka, I.
    Gilissen, R.
    King, P.
    Meerpoel, L.
    Paulussen, C.
    Pilatte, I.
    Poncelet, V.
    Rees, D. C.
    Roux, B.
    Tronel, V.
    Verhulst, T.
    Wroblowski, B.
    Murray, C. W.
    Vialard, J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 115 - 115
  • [29] The effect of syndecan-4 and glypican-1 expression on age-related changes in myogenic satellite cell proliferation, differentiation, and fibroblast growth factor 2 responsiveness
    Harthan, Laura B.
    McFarland, Douglas C.
    Velleman, Sandra G.
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 2013, 166 (04): : 590 - 602
  • [30] Optimization of novel pyrido[2,3-b]pyrazine based small molecule fibroblast growth factor receptor 1, 2, 3 & 4 (FGFR) inhibitors into a potential clinical candidate
    Dey, N.
    De, P.
    Leyland-Jones, B.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 128 - 128